ATE352310T1 - Verwendung von zeoliten zur herstellung oraler zubereitungen zur behandlung von vergiftung - Google Patents
Verwendung von zeoliten zur herstellung oraler zubereitungen zur behandlung von vergiftungInfo
- Publication number
- ATE352310T1 ATE352310T1 AT03010888T AT03010888T ATE352310T1 AT E352310 T1 ATE352310 T1 AT E352310T1 AT 03010888 T AT03010888 T AT 03010888T AT 03010888 T AT03010888 T AT 03010888T AT E352310 T1 ATE352310 T1 AT E352310T1
- Authority
- AT
- Austria
- Prior art keywords
- zeolites
- oral preparations
- preparing oral
- treating poisoning
- poisoning
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Silicates, Zeolites, And Molecular Sieves (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2002MI001246A ITMI20021246A1 (it) | 2002-06-07 | 2002-06-07 | Composizioni minerali detossinanti a base di zeoliti ad elevata capacita' di scambio cationico |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE352310T1 true ATE352310T1 (de) | 2007-02-15 |
Family
ID=29434443
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT03010888T ATE352310T1 (de) | 2002-06-07 | 2003-05-15 | Verwendung von zeoliten zur herstellung oraler zubereitungen zur behandlung von vergiftung |
Country Status (7)
Country | Link |
---|---|
US (1) | US20030228377A1 (de) |
EP (1) | EP1369121B1 (de) |
AT (1) | ATE352310T1 (de) |
DE (1) | DE60311351T2 (de) |
ES (1) | ES2280645T3 (de) |
IT (1) | ITMI20021246A1 (de) |
PT (1) | PT1369121E (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050031708A1 (en) * | 2003-08-06 | 2005-02-10 | Portney Micah S. | Composition comprising a zeolite compound for treatment of diseases |
EP1679962B1 (de) * | 2003-10-20 | 2021-01-13 | Framework Therapeutics, L.L.C. | Zeolit-molekulare siebe für die entfernung von toxinen |
DE102005053090A1 (de) * | 2005-11-04 | 2007-05-10 | Hubert Danz | Verwendung eines aktivierten Zeolithen als pharmazeutisches Mittel für die Reduzierung giftiger Stoffe |
US8951549B2 (en) | 2008-11-21 | 2015-02-10 | Froximun Ag | Method for the reduction of the concentration of amines and salts thereof |
US20100173015A1 (en) * | 2009-01-08 | 2010-07-08 | Reynolds Paul J | Compositions and methods for the absorption, chelation, and elimination of trace elements |
IT1396424B1 (it) * | 2009-06-05 | 2012-11-23 | Hf Europ Srl | Prodotti alimentari comprendenti zeoliti |
IT1403586B1 (it) * | 2010-12-02 | 2013-10-31 | Hf Europ Srl | Nuovo uso di composizioni e di prodotti alimentari comprendenti ossidi e/o idrossidi |
CN109106725A (zh) | 2011-02-11 | 2019-01-01 | Zs制药公司 | 用于治疗高钾血症的微孔性的硅酸锆 |
US9943637B2 (en) | 2012-06-11 | 2018-04-17 | ZS Pharma, Inc. | Microporous zirconium silicate and its method of production |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4627972A (en) * | 1984-11-16 | 1986-12-09 | Union Carbide Corporation | Effervescent dentifrice |
HU206484B (en) * | 1989-03-24 | 1992-11-30 | Orszagos Frederic Joliot Curie | Silicium-containing environment-protecting composition adsorbing radioactive metal-isotopes and toxic heavy metals and process for producing pharmaceutical compositions containing this active component |
ATE160088T1 (de) * | 1995-08-14 | 1997-11-15 | Geomedical S R L | Topische wässrige gele oder suspension auf basis von pulverisiertem vulkanischen oder diagenischem minerale |
-
2002
- 2002-06-07 IT IT2002MI001246A patent/ITMI20021246A1/it unknown
-
2003
- 2003-05-15 PT PT03010888T patent/PT1369121E/pt unknown
- 2003-05-15 DE DE60311351T patent/DE60311351T2/de not_active Expired - Lifetime
- 2003-05-15 ES ES03010888T patent/ES2280645T3/es not_active Expired - Lifetime
- 2003-05-15 EP EP03010888A patent/EP1369121B1/de not_active Expired - Lifetime
- 2003-05-15 AT AT03010888T patent/ATE352310T1/de not_active IP Right Cessation
- 2003-06-04 US US10/453,548 patent/US20030228377A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ITMI20021246A1 (it) | 2003-12-09 |
DE60311351T2 (de) | 2007-05-24 |
EP1369121A1 (de) | 2003-12-10 |
DE60311351D1 (de) | 2007-03-15 |
ES2280645T3 (es) | 2007-09-16 |
EP1369121B1 (de) | 2007-01-24 |
PT1369121E (pt) | 2007-04-30 |
US20030228377A1 (en) | 2003-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20051102L (no) | Sulfonylamino-eddiksyre-derivater | |
IL150986A0 (en) | 1,2,3,4,- tetrahydroisoquinoline derivatives | |
DE602005021770D1 (de) | Indol-1-yl-essigsäurederivate | |
ATE309797T1 (de) | Ibuprofen und diphenhydramin enthaltende zusammensetzungen und deren verwendung zur behandlung von schlafstörungen | |
EA200602191A1 (ru) | 5,5-дизамещённые-2-амино-4-тиазолидиноны и способ их получения, фармацевтическая композиция и способ лечения | |
CO4290417A1 (es) | Nuevas benzoilguanidinas como medicamentos y su preparacion . | |
DE60126947D1 (de) | Behandlung der glykogenspeicherkrankheit typ ii | |
ATE486587T1 (de) | Formulierungen zur oralen verabreichung von wirkstoffen | |
DE602004001857D1 (de) | Thienopyrimidindione und deren verwendung bei der modulierung von autoimmunerkrankungen | |
DE502005008971D1 (de) | Substituierte 1,4,8-triazaspiroä4.5 decan-2-on-verbindungen zur behandlung von fettsucht | |
TW200514772A (en) | Novel tetrahydropyridine derivatives | |
EA200400664A1 (ru) | Фармацевтические композиции, включающие метформин и глибенкламид, применяемые для лечения сахарного диабета типа ii | |
MXPA04001231A (es) | Composiciones topicas para aplicar y no enjuagar que contiene derivados seleccionados del acido pantotenico. | |
ATE527261T1 (de) | 7-aryl-3,9-diazabicycloä3.3.1ünon-6-en-derivate und ihre verwendung als renin-inhibitoren zur behandlung von bluthochdruck, herz-kreislauf- erkrankungen und nierenkrankheiten | |
YU24402A (sh) | 2'-supstituisani 1,1'-bifenil-2-karbonamidi, postupak za njihovu proizvodnju, njihova primena kao leka kao i farmaceutski preparati koji sadrže ta jedinjenja | |
ATE352310T1 (de) | Verwendung von zeoliten zur herstellung oraler zubereitungen zur behandlung von vergiftung | |
ATE312815T1 (de) | Neue verbindungen | |
DE60019086D1 (de) | Zusammensetzungen zur behandlung von hautkrankheiten | |
ATE386525T1 (de) | 3-substituierte 6,7- dihydroxytetrahydroisochinolin-derivate zur verwendung als antibkaterielle mittel | |
ATE422892T1 (de) | Verwendung von hyaluronsäure zur herstellung von zusammensetzungen zur behandlung rekurrenten aphthen in der mundhöhle | |
IL141325A0 (en) | Tan-1057 derivatives | |
Huang et al. | Prevention of the epoxy resin-based root canal sealers-induced cyclooxygenase-2 expression and cytotoxicity of human osteoblastic cells by various antioxidants | |
ATE313541T1 (de) | Benzofuran derivate und ihre verwendung als antibakterielle wirkstoffe | |
NO330964B1 (no) | Kolkisosidanaloger | |
DE69402004D1 (de) | Beta-mercapto-propanamidderivate verwendbar zur Behandlung kardiovaskularer Krankheiten oder Erkrankungen |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1369121 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |